In the analysis of TCGA database, we found that CCL20 and its receptor CCR6, as well as CXCL16 and CX3CL1 were positively correlated with FOXP3 expression in NSCLC patients (Fig. 3b, Supplementary Fig. 6). Here, FOXP3 is linked to non-small cell lung carcinoma.